Crispr’s Next Frontier Is In-Human Treatment, Co-Inventor Says

(Bloomberg) -- As investors await results from the first U.S. clinical trials of the gene-editing system known as Crispr, scientists are focused on finding ways to administer it directly into human...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.